1,337
Views
6
CrossRef citations to date
0
Altmetric
Short Report

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine

, &
Pages 645-648 | Received 29 Jun 2016, Accepted 21 Sep 2016, Published online: 23 Dec 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. R Giuliani, A Mattei, A Appetiti, D Pompei, F Di Donna, F Fiasca & L Fabiani. (2018) Spontanuous Demand For Meningococcal B Vaccination: Effects On Appropriateness And Timing. Human Vaccines & Immunotherapeutics 14:8, pages 2075-2081.
Read now

Articles from other publishers (5)

Christine Robin, Rabah Redjoul, Aude Terrade, Ala-Eddine Deghmane, Ludovic Cabanne, Catherine Cordonnier & Muhamed-Kheir Taha. (2022) Immunogenicity and safety of the meningococcal B recombinant (4CMenB) vaccine in allogeneic hematopoietic cell transplantation recipients. Clinical Microbiology and Infection 28:12, pages 1609-1614.
Crossref
Vittorio Gattini, Marco Napoletano, Alessandra Bonotti, Aldo Mignani, Francesca Cosentino, Giovanni Guglielmi, Poupak Fallahi, Alfonso Cristaudo & Rudy Foddis. (2021) Antimeningococcal Vaccination Coverage Among Healthcare Workers in an Italian University Hospital. Frontiers in Public Health 9.
Crossref
Ala-Eddine Deghmane, Sylvie Haeghebaert, Eva Hong, Améliane Jousset, Anne-Sophie Barret & Muhamed-Kheir Taha. (2020) Emergence of new genetic lineage, ST-9316, of Neisseria meningitidis group W in Hauts-de-France region, France 2013–2018. Journal of Infection 80:5, pages 519-526.
Crossref
Alexandra Thabuis, Karim Tararbit, Muhamed-Kheir Taha, Dominique Dejour-Salamanca, Vincent Ronin, Isabelle Parent du Chatelet & Guillaume Spaccaferri. (2018) Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination. Eurosurveillance 23:28.
Crossref
Michael P. Veve & Vasilios Athans. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 383 413 .